# LASTACAFT — FDA application NDA022134

Informational only - not investment advice.

Application NDA022134 · type NDA · FDA status: approved · original approval 2010-07-28

Listed sponsor: ABBVIE · [ABBV company profile](/company/ABBV/) · exact_unique

Sponsor as listed in Drugs@FDA at retrieval (2026-08-07); FDA sponsor listings can lag ownership transfers.

## FDA application facts

| Product | FDA-listed trade name | Active ingredient | Dosage form | Route | Strength | Marketing status | TE code | RLD |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 001 | LASTACAFT | ALCAFTADINE | SOLUTION/DROPS | OPHTHALMIC | 0.25% | Over-the-counter | not listed | Yes |

## Orange Book patent and exclusivity listings

- Patent 10617695, product 001; listed patent expiry date: 2027-03-19.
- Patent 8664215, product 001; listed patent expiry date: 2027-12-23.

Patent and exclusivity dates are regulatory listings from the FDA Orange Book; no relationship to revenue or future sales is stated or implied.

## Compound cross-links

- ALCAFTADINE · UNII 7Z8O94ECSX · [lmmol compound MWTBKTRZPHJQLH-UHFFFAOYSA-N](https://lmmol.com/compound/MWTBKTRZPHJQLH-UHFFFAOYSA-N)

Ingredient–compound links use FDA openFDA/GSRS identifiers and an exact lmmol InChIKey join. Ingredient names cannot create a link.

## Related pages

- [Sponsor company](/company/ABBV/)
- [FDA-approved application index](/drug/)
- [Large-cap biopharma](/compare/pharma/)

Sources: https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files · https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files · https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA022134. FDA data retrieved 2026-08-07.

Regulatory listing data as published by FDA; not medical or investment advice.